Most lately, it has been recognized that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in similar places as classical opioid receptors, it binds into a big range of endogenous opioids. Unlike most opioid receptors, this receptor functions being a scavenger and does not activate a second